Nephros (NEPH) Cash from Operations Growth (3y) (2013 - 2026)
Nephros (NEPH) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 70.05% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 16.81% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 53.64% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -9.84% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 13.75% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -33.35% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -8.92% |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | -100.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.45% |
| Dec 31, 2025 | 43.40% |
| Sep 30, 2025 | 37.20% |
| Jun 30, 2025 | 43.05% |
| Mar 31, 2025 | 29.65% |
| Dec 31, 2024 | 80.62% |
| Sep 30, 2024 | 11.86% |
| Jun 30, 2024 | -62.39% |
| Mar 31, 2024 | -130.32% |
| Dec 31, 2023 | 43.65% |
| Sep 30, 2023 | 32.56% |
| Jun 30, 2023 | 28.69% |
| Mar 31, 2023 | 29.07% |
| Dec 31, 2022 | -36.36% |
| Sep 30, 2022 | 34.82% |
| Jun 30, 2022 | 6.91% |
| Mar 31, 2022 | -37.12% |
| Dec 31, 2021 | 14.07% |
| Sep 30, 2021 | 6.74% |
| Jun 30, 2021 | 55.67% |